 |
|
Forms of cholangitis to be considered after SARS-CoV-2 infection
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clin Mol Hepatol. 2022;28(4):929-930. Published online 2022 Sep 8 DOI: https://doi.org/10.3350/cmh.2022.0260
|
|
Citations to this article as recorded by
 Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
Clinical and Molecular Hepatology.2023; 29(1): 176. CrossRef SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali
Journal of Clinical Virology Plus.2023; 3(4): 100167. CrossRef Post-COVID-19 cholangiopathy: Systematic review
Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Jonathan Soldera
World Journal of Methodology.2023; 13(4): 296. CrossRef
|